Please use this identifier to cite or link to this item:
http://nopr.niscpr.res.in/handle/123456789/23722Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Shrivastava, Sadhana | - |
| dc.contributor.author | Mathur, R | - |
| dc.date.accessioned | 2013-11-19T05:31:05Z | - |
| dc.date.available | 2013-11-19T05:31:05Z | - |
| dc.date.issued | 2004-09 | - |
| dc.identifier.issn | 0975-1009 (Online); 0019-5189 (Print) | - |
| dc.identifier.uri | http://hdl.handle.net/123456789/23722 | - |
| dc.description | 876-883 | en_US |
| dc.description.abstract | Therapeutic efficacy of EGTA (ethylene glycol bis (2-aminoethyl ether) tetraacetic acid) against cerium intoxicated mice was studied. Administration of cerium showed significant decrease in haemoglobin percentage, RBC counts and blood glucose level with an increase in the activity of serum transaminases and WBC counts. Decrease in the activity of alkaline phosphatase and glycogen content was noted in liver and kidney after cerium exposure. Light and electron microscopical investigations showed that these changes were recouped considerably with the administration of EGTA suggesting its therapeutic efficacy against cerium toxicity. | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | NISCAIR-CSIR, India | en_US |
| dc.relation.ispartofseries | Int Cl7 A61 P | en_US |
| dc.rights | CC Attribution-Noncommercial-No Derivative Works 2.5 India | en_US |
| dc.source | IJEB Vol.42(09) [September 2004] | en_US |
| dc.subject | Cerium | en_US |
| dc.subject | EGTA | en_US |
| dc.subject | Toxicity | en_US |
| dc.subject | Male mice | en_US |
| dc.title | Effectiveness of ethylene glycol bis (2-aminoethyl ether) tetraacetic acid (EGTA) against cerium toxicity | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | IJEB Vol.42(09) [September 2004] | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| IJEB 42(9) 876-883.pdf | 2.04 MB | Adobe PDF | View/Open |
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.